Items Tagged ‘clinical trials’

June 1st, 2016

Landmark Study Provides Insight into Information Gaps for Cancer Patients that Affect Informed Treatment Decision Making

By

Most Cancer Patients Are Inadequately Informed about Clinical Trials and Do Not Seek a Second Opinion According to a recent report, a majority of US cancer patients feel inadequately informed about clinical trials and do not seek a second opinion. While two thirds feel satisfied with the information and attention of their cancer care team, […]

View full entry

Tags: All Cancer Types, cancer, Cancercare, clinical trials, communication, diagnosis, News, patient opinion, planning, treatment


March 28th, 2016

Dose-Dense Chemotherapy for Premenopausal Breast Cancer Improves Survival

By

Premenopausal women who have been diagnosed with breast cancer have improved survival if their chemotherapy doses are delivered every two weeks, compared to every three weeks. These results were recently presented at the 2016 European Breast Cancer Conference (EBCC-10) in the Netherlands. Chemotherapy following surgery is a standard treatment option for premenopausal women diagnosed with […]

View full entry

Tags: Breast Cancer, clinical trials, dose-dense, Metastatic Breast Cancer, News, premenopausal, research, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer


July 7th, 2015

Jakafi® Appears Safe and Effective in Long-Term Disease Control in Polycythemia Vera

By

In patients with polycythemia vera (PV), the drug Jakafi® (ruxolitinib) can help control disease at least one year. These findings were presented at the 20th Congress of the European Hematology Association in Vienna, Austria, June 11–14, 2015.[1] Polycythemia vera is a slow-growing type of blood cancer that belongs to a group of blood disorders called […]

View full entry

Tags: blood cancer, clinical trials, hydrea, jakafi, MPNs, Myeloproliferative Neoplasms MPN, News, polycythemia vera, PV, ruxolitinib